{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:49:36Z","timestamp":1789523376216,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s10067-022-06302-z","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T06:02:51Z","timestamp":1659160971000},"page":"3525-3536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort study"],"prefix":"10.1007","volume":"41","author":[{"given":"Abdulrahman N.","family":"Shams-Eldin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelina","family":"Yafasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"Faurschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Schou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar H.","family":"Gislason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil L.","family":"Fosb\u00f8l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad H.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"issue":"2","key":"6302_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.23736\/s0392-0488.18.05929-1","volume":"153","author":"R Filotico","year":"2018","unstructured":"Filotico R, Mastrandrea V (2018) Cutaneous lupus erythematosus: clinico-pathologic correlation. G Ital Dermatol Venereol 153(2):216\u201329. https:\/\/doi.org\/10.23736\/s0392-0488.18.05929-1","journal-title":"G Ital Dermatol Venereol"},{"issue":"9","key":"6302_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41584-019-0272-0","volume":"15","author":"J Wenzel","year":"2019","unstructured":"Wenzel J (2019) Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies. Nat Rev Rheumatol 15(9):519\u2013532. https:\/\/doi.org\/10.1038\/s41584-019-0272-0","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"6302_CR3","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1111\/j.1610-0387.2007.06554.x","volume":"5","author":"A Kuhn","year":"2007","unstructured":"Kuhn A, Sticherling M, Bonsmann G (2007) Clinical manifestations of cutaneous lupus erythematosus. J Dtsch Dermatol Ges 5(12):1124\u20131137. https:\/\/doi.org\/10.1111\/j.1610-0387.2007.06554.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"6302_CR4","doi-asserted-by":"publisher","first-page":"k1036","DOI":"10.1136\/bmj.k1036","volume":"361","author":"BR England","year":"2018","unstructured":"England BR, Thiele GM, Anderson DR, Mikuls TR (2018) Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. Bmj 361:k1036. https:\/\/doi.org\/10.1136\/bmj.k1036","journal-title":"Bmj"},{"issue":"2","key":"6302_CR5","doi-asserted-by":"publisher","first-page":"e56944","DOI":"10.1371\/journal.pone.0056944","volume":"8","author":"SL Kristensen","year":"2013","unstructured":"Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Jensen GV, Torp-Pedersen C et al (2013) Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death\u2013a Danish nationwide cohort study. PLoS ONE 8(2):e56944. https:\/\/doi.org\/10.1371\/journal.pone.0056944","journal-title":"PLoS ONE"},{"issue":"7","key":"6302_CR6","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ejhf.113","volume":"16","author":"U Khalid","year":"2014","unstructured":"Khalid U, Ahlehoff O, Gislason GH, Kristensen SL, Skov L, Torp-Pedersen C et al (2014) Psoriasis and risk of heart failure: a nationwide cohort study. Eur J Heart Fail 16(7):743\u2013748. https:\/\/doi.org\/10.1002\/ejhf.113","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"6302_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1177\/0961203317716306","volume":"26","author":"O Ahlehoff","year":"2017","unstructured":"Ahlehoff O, Wu JJ, Rauns\u00f8 J, Kristensen SL, Khalid U, Kofoed K et al (2017) Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study. Lupus 26(13):1435\u20131439. https:\/\/doi.org\/10.1177\/0961203317716306","journal-title":"Lupus"},{"issue":"2","key":"6302_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10067-020-05257-3","volume":"40","author":"LN Guo","year":"2021","unstructured":"Guo LN, Nambudiri VE (2021) Cutaneous lupus erythematosus and cardiovascular disease: current knowledge and insights into pathogenesis. Clin Rheumatol 40(2):491\u2013499. https:\/\/doi.org\/10.1007\/s10067-020-05257-3","journal-title":"Clin Rheumatol"},{"issue":"1","key":"6302_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/0961203316651739","volume":"26","author":"JH Hesselvig","year":"2017","unstructured":"Hesselvig JH, Ahlehoff O, Dreyer L, Gislason G, Kofoed K (2017) Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. Lupus 26(1):48\u201353. https:\/\/doi.org\/10.1177\/0961203316651739","journal-title":"Lupus"},{"issue":"11","key":"6302_CR10","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/acr.22892","volume":"68","author":"AG Singh","year":"2016","unstructured":"Singh AG, Crowson CS, Singh S, Denis M, Davis P, Maradit-Kremers H et al (2016) Risk of cerebrovascular accidents and ischemic heart disease in cutaneous lupus erythematosus: a population-based cohort study. Arthritis Care Res (Hoboken) 68(11):1664\u20131670. https:\/\/doi.org\/10.1002\/acr.22892","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"6302_CR11","doi-asserted-by":"publisher","first-page":"102794","DOI":"10.1016\/j.autrev.2021.102794","volume":"20","author":"C Kirchler","year":"2021","unstructured":"Kirchler C, Husar-Memmer E, Rappersberger K, Thaler K, Fritsch-Stork R (2021) Type I Interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: a systematic review. Autoimmun Rev 20(5):102794. https:\/\/doi.org\/10.1016\/j.autrev.2021.102794","journal-title":"Autoimmun Rev"},{"issue":"9474","key":"6302_CR12","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/s0140-6736(05)66621-4","volume":"365","author":"JJ McMurray","year":"2005","unstructured":"McMurray JJ, Pfeffer MA (2005) Heart failure. Lancet 365(9474):1877\u20131889. https:\/\/doi.org\/10.1016\/s0140-6736(05)66621-4","journal-title":"Lancet"},{"issue":"2","key":"6302_CR13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/art.22375","volume":"56","author":"RM Andrade","year":"2007","unstructured":"Andrade RM, Alarc\u00f3n GS, Fern\u00e1ndez M, Apte M, Vil\u00e1 LM, Reveille JD (2007) Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum 56(2):622\u201330","journal-title":"Arthritis Rheum"},{"issue":"1","key":"6302_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13293-019-0274-2","volume":"10","author":"JI Ram\u00edrez Sep\u00falveda","year":"2019","unstructured":"Ram\u00edrez Sep\u00falveda JI, Bolin K, Mofors J, Leonard D, Svenungsson E, J\u00f6nsen A et al (2019) Sex differences in clinical presentation of systemic lupus erythematosus. Biol Sex Differ 10(1):60. https:\/\/doi.org\/10.1186\/s13293-019-0274-2","journal-title":"Biol Sex Differ"},{"issue":"7","key":"6302_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1365-2230.2009.03764.x","volume":"35","author":"MA Vera-Recabarren","year":"2010","unstructured":"Vera-Recabarren MA, Garc\u00eda-Carrasco M, Ramos-Casals M, Herrero C (2010) Cutaneous lupus erythematosus: clinical and immunological study of 308 patients stratified by gender. Clin Exp Dermatol 35(7):729\u2013735. https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03764.x","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"6302_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/s1550-8579(04)80006-8","volume":"1","author":"SZ YacoubWasef","year":"2004","unstructured":"YacoubWasef SZ (2004) Gender differences in systemic lupus erythematosus. Gend Med 1(1):12\u20137. https:\/\/doi.org\/10.1016\/s1550-8579(04)80006-8","journal-title":"Gend Med"},{"key":"6302_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2147\/clep.S179083","volume":"11","author":"M Schmidt","year":"2019","unstructured":"Schmidt M, Schmidt SAJ, Adelborg K, Sundb\u00f8ll J, Laugesen K, Ehrenstein V et al (2019) The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol 11:563\u2013591. https:\/\/doi.org\/10.2147\/clep.S179083","journal-title":"Clin Epidemiol"},{"issue":"7 Suppl","key":"6302_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","volume":"39","author":"E Lynge","year":"2011","unstructured":"Lynge E, Sandegaard JL, Rebolj M (2011) The Danish National Patient Register. Scand J Public Health 39(7 Suppl):30\u201333. https:\/\/doi.org\/10.1177\/1403494811401482","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"6302_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"HW Kildemoes","year":"2011","unstructured":"Kildemoes HW, S\u00f8rensen HT (2011) Hallas J (2011) The Danish National Prescription Registry. Scand J Public Health 39(7 Suppl):38\u201341. https:\/\/doi.org\/10.1177\/1403494810394717","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"6302_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen CB (2011) The Danish Civil Registration System. Scand J Public Health 39(7 Suppl):22\u201325. https:\/\/doi.org\/10.1177\/1403494810387965","journal-title":"Scand J Public Health"},{"issue":"15","key":"6302_CR21","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1161\/circulationaha.107.720847","volume":"117","author":"TK Schramm","year":"2008","unstructured":"Schramm TK, Gislason GH, K\u00f8ber L, Rasmussen S, Rasmussen JN, Abildstr\u00f8m SZ et al (2008) Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 117(15):1945\u201354. https:\/\/doi.org\/10.1161\/circulationaha.107.720847","journal-title":"Circulation"},{"key":"6302_CR22","doi-asserted-by":"publisher","first-page":"d124","DOI":"10.1136\/bmj.d124","volume":"342","author":"JB Olesen","year":"2011","unstructured":"Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J et al (2011) Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 342:d124. https:\/\/doi.org\/10.1136\/bmj.d124","journal-title":"BMJ"},{"issue":"12","key":"6302_CR23","doi-asserted-by":"publisher","first-page":"e012817","DOI":"10.1136\/bmjopen-2016-012817","volume":"6","author":"K Adelborg","year":"2016","unstructured":"Adelborg K, Sundb\u00f8ll J, Munch T, Fr\u00f8slev T, S\u00f8rensen HT, B\u00f8tker HE et al (2016) Positive predictive value of cardiac examination, procedure and surgery codes in the Danish National Patient Registry: a population-based validation study. BMJ Open 6(12):e012817. https:\/\/doi.org\/10.1136\/bmjopen-2016-012817","journal-title":"BMJ Open"},{"issue":"4","key":"6302_CR24","first-page":"A5470","volume":"65","author":"J Delekta","year":"2018","unstructured":"Delekta J, Hansen SM, AlZuhairi KS, Bork CS, Joensen AM (2018) The validity of the diagnosis of heart failure (I50.0\u2013I50.9) in the Danish National Patient Register. Dan Med J 65(4):A5470","journal-title":"Dan Med J"},{"issue":"3","key":"6302_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000102143","volume":"28","author":"LH Krarup","year":"2007","unstructured":"Krarup LH, Boysen G, Janjua H, Prescott E, Truelsen T (2007) Validity of stroke diagnoses in a National Register of Patients. Neuroepidemiology 28(3):150\u2013154. https:\/\/doi.org\/10.1159\/000102143","journal-title":"Neuroepidemiology"},{"issue":"7","key":"6302_CR26","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.ejheart.2008.05.006","volume":"10","author":"T K\u00fcmler","year":"2008","unstructured":"K\u00fcmler T, Gislason GH, Kirk V, Bay M, Nielsen OW, K\u00f8ber L et al (2008) Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail 10(7):658\u2013660. https:\/\/doi.org\/10.1016\/j.ejheart.2008.05.006","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"6302_CR27","doi-asserted-by":"publisher","first-page":"e012832","DOI":"10.1136\/bmjopen-2016-012832","volume":"6","author":"J Sundb\u00f8ll","year":"2016","unstructured":"Sundb\u00f8ll J, Adelborg K, Munch T, Fr\u00f8slev T, S\u00f8rensen HT, B\u00f8tker HE et al (2016) Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open 6(11):e012832. https:\/\/doi.org\/10.1136\/bmjopen-2016-012832","journal-title":"BMJ Open"},{"key":"6302_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2288-11-83","volume":"11","author":"SK Thygesen","year":"2011","unstructured":"Thygesen SK, Christiansen CF, Christensen S, Lash TL, S\u00f8rensen HT (2011) The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 11:83. https:\/\/doi.org\/10.1186\/1471-2288-11-83","journal-title":"BMC Med Res Methodol"},{"issue":"10","key":"6302_CR29","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1007\/s10067-016-3373-z","volume":"35","author":"J Chen","year":"2016","unstructured":"Chen J, Tang Y, Zhu M, Xu A (2016) Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis. Clin Rheumatol 35(10):2437\u20132448. https:\/\/doi.org\/10.1007\/s10067-016-3373-z","journal-title":"Clin Rheumatol"},{"issue":"3","key":"6302_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.tcm.2017.08.015","volume":"28","author":"BP Dhakal","year":"2018","unstructured":"Dhakal BP, Kim CH, Al-Kindi SG, Oliveira GH (2018) Heart failure in systemic lupus erythematosus. Trends Cardiovasc Med 28(3):187\u2013197. https:\/\/doi.org\/10.1016\/j.tcm.2017.08.015","journal-title":"Trends Cardiovasc Med"},{"issue":"3","key":"6302_CR31","doi-asserted-by":"publisher","first-page":"e33442","DOI":"10.1371\/journal.pone.0033442","volume":"7","author":"B Z\u00f6ller","year":"2012","unstructured":"Z\u00f6ller B, Li X, Sundquist J, Sundquist K (2012) Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS ONE 7(3):e33442. https:\/\/doi.org\/10.1371\/journal.pone.0033442","journal-title":"PLoS ONE"},{"issue":"7","key":"6302_CR32","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2165\/00128071-200304070-00002","volume":"4","author":"P Fabbri","year":"2003","unstructured":"Fabbri P, Cardinali C, Giomi B, Caproni M (2003) Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol 4(7):449\u2013465. https:\/\/doi.org\/10.2165\/00128071-200304070-00002","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"6302_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s1388-9842(00)00141-0","volume":"3","author":"S Stewart","year":"2001","unstructured":"Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ (2001) More \u201cmalignant\u201d than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 3(3):315\u2013322. https:\/\/doi.org\/10.1016\/s1388-9842(00)00141-0","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"6302_CR34","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jaad.2020.12.013","volume":"84","author":"JH Haugaard","year":"2021","unstructured":"Haugaard JH, Dreyer L, Ottosen MB, Gislason G, Kofoed K, Egeberg A (2021) Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: a Danish nationwide cohort study. J Am Acad Dermatol 84(4):930\u2013937. https:\/\/doi.org\/10.1016\/j.jaad.2020.12.013","journal-title":"J Am Acad Dermatol"},{"issue":"13","key":"6302_CR35","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1177\/0961203316651745","volume":"25","author":"P Jarrett","year":"2016","unstructured":"Jarrett P, Thornley S, Scragg R (2016) Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand. Lupus 25(13):1497\u20131502. https:\/\/doi.org\/10.1177\/0961203316651745","journal-title":"Lupus"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06302-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06302-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06302-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T09:16:33Z","timestamp":1665738993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06302-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["6302"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06302-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the data responsible institute (the Capital Region of Denmark [approval number: P-2019\u2013348]) in accordance with the General Data Protection Regulation. In Denmark, there is no requirement for ethics committee approval in registry-based studies in which individuals cannot be identified.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors have read and approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}